Glucocorticoids_NNS
and_CC
interferon-alpha_NN
in_IN
the_DT
acquired_VBN
immunodeficiency_NN
syndrome_NN
._.

Some_DT
patients_NNS
with_IN
acquired_VBN
immunodeficiency_NN
syndrome_NN
-LRB-_-LRB-
AIDS_NN
-RRB-_-RRB-
develop_VBP
glucocorticoid_NN
resistance_NN
characterized_VBN
by_IN
low_JJ
receptor_NN
affinity_NN
-LRB-_-LRB-
Kd_NN
-RRB-_-RRB-
for_IN
glucocorticoids_NNS
in_IN
mononuclear_JJ
,_,
cells_NNS
and_CC
high_JJ
values_NNS
of_IN
ACTH_NN
and_CC
cortisol_NN
._.

As_IN
glucocorticoids_NNS
regulate_VBP
interferon-alpha_NN
-LRB-_-LRB-
IFN_NN
alpha_NN
-RRB-_-RRB-
production_NN
,_,
we_PRP
hypothesized_VBD
that_IN
IFN_NN
alpha_NN
,_,
a_DT
cytokine_NN
produced_VBN
predominantly_RB
by_IN
monocytes_NNS
in_IN
AIDS_NN
,_,
should_MD
be_VB
increased_VBN
in_IN
cortisol-resistant_JJ
AIDS_NN
,_,
attributing_VBG
the_DT
lack_NN
of_IN
cortisol_NN
inhibition_NN
to_TO
IFN_NN
alpha_NN
production_NN
._.

Therefore_RB
,_,
we_PRP
examined_VBD
glucocorticoid_NN
receptor_NN
characteristics_NNS
on_IN
monocytes_NNS
by_IN
-LCB-_-LRB-
3H-RCB-dexamethasone_JJ
binding_NN
and_CC
measured_VBN
IFN_NN
alpha_NN
,_,
cortisol_NN
,_,
and_CC
ACTH_NN
in_IN
AIDS_NN
patients_NNS
with_IN
-LRB-_-LRB-
AIDS-GR_NN
-RRB-_-RRB-
or_CC
without_IN
glucocorticoid_NN
resistance_NN
-LRB-_-LRB-
AIDS-C_NN
-RRB-_-RRB-
and_CC
controls_NNS
-LRB-_-LRB-
C_NN
-RRB-_-RRB-
._.

Monocytes_NNS
of_IN
AIDS-GR_NN
patients_NNS
had_VBD
a_DT
receptor_NN
Kd_NN
of_IN
10.5_NN
+_CC
\/_CD
-_TO
4.2_CD
nmol\/L_NN
that_WDT
was_VBD
higher_JJR
than_IN
that_DT
in_IN
the_DT
AIDS-C_NN
group_NN
-LRB-_-LRB-
2.9_CD
+_CC
\/_NN
-_:
0.8_CD
nmol\/L_NN
-RRB-_-RRB-
and_CC
normal_JJ
subjects_NNS
-LRB-_-LRB-
2.0_CD
+_CC
\/_CD
-_:
0.8_CD
nmol\/L_NN
;_:
P_NN
&lt;_JJR
0.01_CD
-RRB-_-RRB-
._.

IFN_NN
alpha_NN
levels_NNS
were_VBD
increased_VBN
in_IN
the_DT
AIDS-GR_NN
group_NN
-LRB-_-LRB-
17_CD
+_CC
\/_NN
-_:
6_CD
vs._CC
4_CD
+_CC
\/_NN
-_:
1_CD
U\/mL_NN
in_IN
the_DT
AIDS-C_NN
group_NN
and_CC
2_CD
+_CC
\/_CD
-_:
0.5_CD
U\/mL_NN
in_IN
the_DT
C_NN
group_NN
;_:
P_NN
&lt;_JJR
0.01_CD
-RRB-_-RRB-
._.

Correlations_NNS
were_VBD
found_VBN
between_IN
plasma_NN
IFN_NN
alpha_NN
and_CC
receptor_NN
Kd_NN
on_IN
monocytes_NNS
of_IN
AIDS-GR_NN
-LRB-_-LRB-
r_NN
=_JJ
0.77_CD
-RRB-_-RRB-
and_CC
between_IN
IFN_NN
alpha_NN
and_CC
plasma_NN
cortisol_NN
in_IN
the_DT
same_JJ
group_NN
-LRB-_-LRB-
r_NN
=_JJ
0.74_CD
-RRB-_-RRB-
._.

The_DT
poly_VBN
-LRB-_-LRB-
I_NN
-RRB-_-RRB-
-_:
poly_NN
-LRB-_-LRB-
C_NN
-RRB-_-RRB-
-_:
induced_VBD
IFN_NN
alpha_NN
production_NN
by_IN
monocytes_NNS
was_VBD
inhibited_VBN
by_IN
glucocorticoids_NNS
in_IN
the_DT
C_NN
and_CC
AIDS-C_NN
groups_NNS
-LRB-_-LRB-
approximately_RB
80_CD
%_NN
inhibition_NN
in_IN
both_DT
groups_NNS
-RRB-_-RRB-
;_:
the_DT
effect_NN
was_VBD
reversed_VBN
by_IN
the_DT
receptor_NN
antagonist_NN
RU-38486_NN
._.

By_IN
contrast_NN
,_,
glucocorticoids_NNS
failed_VBD
to_TO
inhibit_VB
IFNalpha_NN
production_NN
from_IN
AIDS-GR_NN
monocytes_NNS
-LRB-_-LRB-
approximately_RB
20_CD
%_NN
inhibition_NN
-RRB-_-RRB-
._.

In_IN
conclusion_NN
,_,
elevated_JJ
IFN_NN
alpha_NN
levels_NNS
in_IN
AIDS-GR_NN
may_MD
be_VB
due_JJ
to_TO
the_DT
lack_NN
of_IN
inhibitory_JJ
effect_NN
of_IN
cortisol_NN
on_IN
IFN_NN
alpha_NN
production_NN
due_JJ
to_TO
cortisol_NN
resistance_NN
in_IN
monocytes_NNS
._.

